LGIH
LGI Homes, Inc.
LGIH trails on the overall score without a compensating advantage in the available component scores.
NIO
NIO Inc.
NIO has the edge over LGIH overall, supported by stronger fundamentals and stronger valuation.
LGIH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Strong |
LGIH's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
LGIH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.8x | $20.61 | -50% |
| Fair | 11x | $33.17 | -19% |
| Expensive | 14x | $42.66 | +3.7% |
| Current | 14x | $41.12 | — |
| Forward | 15x | $41.12 | — |
Historical ranges are pointers, not guarantees.
LGIH's PE is in its expensive range at 14x. On analysts' estimates for next year's earnings, today's price would be 15x.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
LGIH Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect LGIH's earnings, revenue and profitability to hold roughly steady. However, they disagree widely on these estimates.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
NIO has the edge over LGIH on the outlook, with more favorable earnings and revenue expectations.
LGIH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.67 | -12% |
| Q3 2026 | $3.04 | -33% |
| Q2 2026 | $2.84 | -57% |
| Q1 2026 | $3.04 | -61% |
| Q4 2025 | $3.12 | -62% |
| Q3 2025 | $4.53 | -46% |
| Q2 2025 | $6.63 | -19% |
| Q1 2025 | $7.75 | -3.1% |
| Q4 2024 | $8.30 | -1.4% |
LGIH has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
LGIH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $444.5M | +12% |
| Q2 2026 | $516M | +6.7% |
| Q1 2026 | $319.7M | -9% |
| Q4 2025 | $474M | -15% |
| Q3 2025 | $396.6M | -39% |
| Q2 2025 | $483.5M | -20% |
| Q1 2025 | $351.4M | -10% |
| Q4 2024 | $557.4M | -8.4% |
LGIH's revenue is recovering but still below its 2020 peak: $444M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.5% | +2.1 points |
| Q2 2026 | 7.1% | -1.1 points |
| Q1 2026 | -0.2% | -0.2 points |
| Q4 2025 | 3.9% | -4.3 points |
| Q3 2025 | 5.4% | -6.9 points |
| Q2 2025 | 8.2% | -3 points |
| Q1 2025 | 0.1% | -4.7 points |
| Q4 2024 | 8.2% | -1.7 points |
LGIH has the edge over NIO on profitability, with a higher operating margin.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over LGIH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
LGIH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $37.9M | +$51.2M |
| Q2 2026 | $113.7M | +$200.2M |
| Q1 2026 | -$56.2M | +$71.7M |
| Q4 2025 | $86.8M | +54% |
| Q3 2025 | -$13.3M | +$4.6M |
| Q2 2025 | -$86.4M | -$2.7M |
| Q1 2025 | -$128M | -$27.5M |
| Q4 2024 | $56.4M | +$90.7M |
LGIH has the edge over NIO on cash flow, with more consistent year-over-year improvement.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
LGIH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
| Q4 2025 | 19.0x | High |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 6.6x | High |
LGIH has more cash than debt.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LGIH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 20.0 | Oversold |
LGIH's weekly RSI is 38 (neutral) and its Stochastic is 20 (oversold).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
LGIH PE vs Consumer Cyclical Sector
| Metric | LGIH | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 18x | 25% below |
| PE % | 80 | 47 | 33 pts above |
LGIH is trading at 14x earnings, a 25% discount to the Consumer Cyclical sector's median of 18x.
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
LGIH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.8 | 8.2% below |
| 20 week MA | $52.1 | 21% below |
| 50 week MA | $49.7 | 17% below |
| 100 week MA | $56.1 | 27% below |
| 200 week MA | $83.9 | 51% below |
LGIH is in a downtrend: it's below all five of its weekly moving averages, and 51% below its 200-week average.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
LGIH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $70.5 | $112.7 | +60% |
| 2021 | $112.7 | $152.2 | +35% |
| 2022 | $152.2 | $94.8 | -38% |
| 2023 | $94.8 | $133.2 | +40% |
| 2024 | $133.2 | $89.6 | -33% |
| 2025 | $89.6 | $43.2 | -52% |
| 2026 YTD | $43.2 | $41.1 | -4.8% |
LGIH has the edge over NIO on returns for 2026, with the stronger performance.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.